Senesco Technologies, Inc was Eloxx Pharmaceuticals’s largest revenue line in fiscal 2014, bringing in $100.00K of $182.23K (55%).
| Related Party | FY 2014 |
|---|---|
| Senesco Technologies, Inc | $100.00K |
| Fabrus, Inc | $82.23K |
| Total | $182.23K |
Eloxx Pharmaceuticals brought in $182.23K from its two revenue lines in fiscal 2014, the year ended June 30, 2014. Senesco Technologies, Inc was the largest at $100.00K (54.9%), ahead of Fabrus, Inc at $82.23K (45.1%).
Eloxx Pharmaceuticals (ELOX) reports its revenue by related party. In fiscal 2014, Senesco Technologies, Inc was its largest revenue line, bringing in $100.00K (54.9% of the total), followed by Fabrus, Inc at $82.23K (45.1%).
Senesco Technologies, Inc was Eloxx Pharmaceuticals' largest revenue line in fiscal 2014, bringing in $100.00K, or 54.9% of the $182.23K total across its two revenue lines.
Every figure comes from Eloxx Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Eloxx Pharmaceuticals gives it, and years follow its fiscal calendar.
Eloxx Pharmaceuticals' revenue by related party goes back to fiscal 2014, with figures through fiscal 2014. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.